Discover 1,440 paid clinical trials in Quebec. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 1,440
Dynamo: a Tailored Lifestyle Promotion Intervention Among Pediatric Patients With Cardiometabolic Risk Factors
for
Obese
Location: Montreal
Sponsor: St. Justine's Hospital
Sex: All
Age: 6 - 18
Code: NCT01736748
Recruiting
Impact of Different Dialysis on Sleep Apnea in Patients With Renal Failure
for
Sleep Apnea, End Stage Renal Disease
Location: Montreal
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Sex: All
Age: 18+
Code: NCT00380848
Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
for
Parkinsons Disease (PD)
Location: Boston MA, Providence RI, New York NY, Burlington VT,
Sponsor: BlueRock Therapeutics
Sex: All
Age: 45 - 70+
Code: NCT06944522
Phase3, Recruiting
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
for
Immunoglobulin A Nephropathy (IgAN)
Location: Boston MA, Providence RI, The Bronx NY, Montreal,
Sponsor: Biogen
Sex: All
Age: 18+
Code: NCT06935357
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: St. John's, Halifax, Boston MA, Quebec, Bronx NY,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase3, Recruiting
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
for
Solid Tumors, Hematologic Malignancies
Location: Quebec, Sherbrooke, White Plains NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT03486873
Phase3, Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
for
Acute Myeloid Leukemia
Location: Halifax, Bangor ME, Scarborough ME, Boston MA,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT04293562
Phase3, Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
for
H3 K27M, Glioma
Location: Montreal, Ottawa, Toronto, London, Calgary, Vancouver
Sponsor: Jazz Pharmaceuticals
Sex: All
Age: 0+
Code: NCT05580562
Phase3, Recruiting
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment
for
Eosinophilic Asthma
Location: Warwick RI, Quebec, Sainte-Foy, New Hyde Park NY,
Sponsor: AstraZeneca
Sex: All
Age: 12 - 70+
Code: NCT06750289
Phase3, Recruiting
Updating Preventive and Treatment Guidelines for Hypoglycemia in Individuals Living With Type 1 Diabetes
for
Type 1 Diabetes
Location: Montreal
Sponsor: Institut de Recherches Cliniques de Montreal
Sex: All
Age: 18+
Code: NCT06683391
Recruiting
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability